reported that IL-10 rs1800872 GG genotypes predicted the worse survival of diffuse large B-cell lymphoma patients treated with rituximab-CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) [56]. This evidence concerns the gene IL10 and diffuse large B-cell lymphoma.